Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 15
- 13F valueReported value at the end of Q2 2026
- $568.7K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PULM, Q2 2026
No superinvestor reported holding PULM at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Pulmatrix, Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Pulmatrix, Inc. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Pulmatrix, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 122,698 | $208.6K | 0.00% | +13,550+12.4% | Added |
| BlackRock, Inc. | 54,899 | $93.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 33,299 | $56.6K | 0.00% | −11,330−25.4% | Reduced |
| Vanguard Capital Management LLC | 32,294 | $54.9K | 0.00% | −1,300−3.9% | Reduced |
| SBI Securities Co., Ltd. | 31,285 | $53.2K | 0.00% | +1,200+4.0% | Added |
| Shay Capital LLC | 18,857 | $32.1K | 0.00% | +18,857 | New |
| Vanguard Fiduciary Trust Co | 14,715 | $25.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 13,945 | $23.7K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,991 | $20.4K | 0.00% | −1,678−12.3% | Reduced |
| UBS Group AG | 515 | $875 | 0.00% | +492+2,139.1% | Added |